1Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995,122: 561.
3Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin- induced tissue injury. J Neurosci 1992,12: 3665.
4Caleutt NA. Potential mechanisms of neuropathie pain in diabetes. Int Rev Neurobiol 2002,50: 205.
5Rull JA, Quibrera R, Gonzalez - Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with earbamazepine:double- blind crossover trial. Diabetologia 1969,5.- 215.
6Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974,48 : 869.
7Koehar DK, Jain N, Agarwal RP, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002,106:248.
8Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977,22: 196.
9Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998,280: 1831.
10Iacobellis D, Allen R, Lamoreaux L, et al. A double - blind,plaeebo - controlled trial of pregabalin for the treatment of painful diabetie peripheral neuropathy [ abasstraet ]. Neurology 20003 54 Suppl. 3: A177.
